Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Gerner

Showing results (191-200 of 211) with videos related to

Pageof 22
Sort By:
Journal of Medicinal Chemistry|January 27, 2026
Structure-Activity Relationships of Silver(I)- and Gold(I)-NHC Complexes Reveal Distinctly Different Responses of Cisplatin-Resistant Ovarian Cancer to Bis-NHC-Gold(I) DerivativesJulia H Bormio Nunes, Christina Hacker, Monika Caban, et al.
Elife|June 14, 2018
iTAP, a novel iRhom interactor, controls TNF secretion by policing the stability of iRhom/TACEIoanna Oikonomidi, Emma Burbridge, Miguel Cavadas, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 22, 2023
Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatinAlexander Ries, Daniela Flehberger, Astrid Slany, et al.
Nature Ecology & Evolution|January 12, 2021
Seasonal variation in UVA light drives hormonal and behavioural changes in a marine annelid via a ciliary opsinVinoth Babu Veedin Rajan, N Sören Häfker, Enrique Arboleda, et al.
International Journal of Cancer|February 18, 2020
Lipid droplet-mediated scavenging as novel intrinsic and adaptive resistance factor against the multikinase inhibitor ponatinibBernhard Englinger, Anna Laemmerer, Patrick Moser, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|October 12, 2022
Highly Cytotoxic Molybdenocenes with Strong Metabolic Effects Inhibit Tumour Growth in MiceValentin Fuchs, Klaudia Cseh, Michaela Hejl, et al.
Iscience|December 12, 2022
A multi-omics based anti-inflammatory immune signature characterizes long COVID-19 syndromeJohannes J Kovarik, Andrea Bileck, Gerhard Hagn, et al.
Chemical Science|August 6, 2025
Selectivity for TP53 signalling drives the mode of action of a highly potent <i>N</i>,<i>O</i>,<i>O</i>-tridentate naphthoquinone-based organo-ruthenium anticancer drug candidateAlexander Rosner, Lukas Skos, Theresa Mendrina, et al.
Journal of Proteome Research|September 26, 2024
Automated High-Throughput Biological Sex Identification from Archeological Human Dental Enamel Using Targeted ProteomicsClaire Koenig, Patricia Bortel, Ryan S Paterson, et al.
Cells|June 10, 2023
Aberrant DNA Methylation, Expression, and Occurrence of Transcript Variants of the ABC Transporter Katja Zappe, Antonio Kopic, Alexandra Scheichel, et al.
Pageof 22

Showing results (191-200 of 211) with videos related to

Sort By:
Pageof 22
Journal of Medicinal Chemistry|January 27, 2026
Structure-Activity Relationships of Silver(I)- and Gold(I)-NHC Complexes Reveal Distinctly Different Responses of Cisplatin-Resistant Ovarian Cancer to Bis-NHC-Gold(I) DerivativesJulia H Bormio Nunes, Christina Hacker, Monika Caban, et al.
Elife|June 14, 2018
iTAP, a novel iRhom interactor, controls TNF secretion by policing the stability of iRhom/TACEIoanna Oikonomidi, Emma Burbridge, Miguel Cavadas, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 22, 2023
Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatinAlexander Ries, Daniela Flehberger, Astrid Slany, et al.
Nature Ecology & Evolution|January 12, 2021
Seasonal variation in UVA light drives hormonal and behavioural changes in a marine annelid via a ciliary opsinVinoth Babu Veedin Rajan, N Sören Häfker, Enrique Arboleda, et al.
International Journal of Cancer|February 18, 2020
Lipid droplet-mediated scavenging as novel intrinsic and adaptive resistance factor against the multikinase inhibitor ponatinibBernhard Englinger, Anna Laemmerer, Patrick Moser, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|October 12, 2022
Highly Cytotoxic Molybdenocenes with Strong Metabolic Effects Inhibit Tumour Growth in MiceValentin Fuchs, Klaudia Cseh, Michaela Hejl, et al.
Iscience|December 12, 2022
A multi-omics based anti-inflammatory immune signature characterizes long COVID-19 syndromeJohannes J Kovarik, Andrea Bileck, Gerhard Hagn, et al.
Chemical Science|August 6, 2025
Selectivity for TP53 signalling drives the mode of action of a highly potent <i>N</i>,<i>O</i>,<i>O</i>-tridentate naphthoquinone-based organo-ruthenium anticancer drug candidateAlexander Rosner, Lukas Skos, Theresa Mendrina, et al.
Journal of Proteome Research|September 26, 2024
Automated High-Throughput Biological Sex Identification from Archeological Human Dental Enamel Using Targeted ProteomicsClaire Koenig, Patricia Bortel, Ryan S Paterson, et al.
Cells|June 10, 2023
Aberrant DNA Methylation, Expression, and Occurrence of Transcript Variants of the ABC Transporter Katja Zappe, Antonio Kopic, Alexandra Scheichel, et al.
Pageof 22